Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Medtronic (MDT)

Medtronic completes MiniMed separation after exchange offer settles

Neutral Impact 4 of 5 restructuring

Medtronic said on October 15, 2026 that its exchange offer for MiniMed Group shares had settled and the separation was complete. The offer was 5.4 times subscribed, and Medtronic exchanged its remaining 252,813,348 MiniMed shares, ending its ownership stake in MiniMed. The same filing reports shareholder approval of all six AGM proposals and a leadership expansion for Michael Marinaro, with a base salary of $1,000,000 for fiscal 2027.

Key points

  • Exchange offer settled October 15, 2026; Medtronic exchanged all remaining interest, 252,813,348 MiniMed shares, and the offer was 5.4 times subscribed
  • Michael Marinaro appointed President, Medtronic, effective October 14, 2026, with oversight of Greater China operations; base salary set at $1,000,000 for fiscal 2027
  • Supplemental fiscal 2027 long-term incentive awards with an aggregate target value of approximately $3.25 million, to be granted November 2, 2026
  • All twelve director nominees were elected at the October 15, 2026 Annual General Meeting, and all six proposals passed

The filing

CompanyMedtronic (MDT)
Form8-K, current report
Filed with the SECOct 19, 2026, 4:23 PM ET
Accession number0001628280-26-066291

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 7, 2026, 11:18 PM ET, from the text of the filing and its press-release exhibits only.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.